TRNS Overview

Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.

Wall Street analysts forecast TRNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TRNS is100.00 USD with a low forecast of 95.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Transcat Inc revenue for the last quarter amounts to 83.86M USD, increased 25.62

Transcat Inc. EPS for the last quarter amounts to -0.12 USD, decreased -148.00

Transcat Inc (TRNS) has 1245 emplpoyees as of March 12 2026.

Today TRNS has the market capitalization of 693.94M USD.